These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36526642)

  • 21. Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.
    Chen L; Schiffer JM; Dalton S; Sabourin CL; Niemuth NA; Plikaytis BD; Quinn CP
    Clin Vaccine Immunol; 2014 Nov; 21(11):1512-20. PubMed ID: 25185577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin's binding subunit.
    Rong Y; Van Slyke G; Vance DJ; Westfall J; Ehrbar D; Mantis NJ
    PLoS One; 2017; 12(7):e0180999. PubMed ID: 28700745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
    Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
    PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
    Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
    Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
    Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
    Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant.
    Kende M; Del Giudice G; Rivera N; Hewetson J
    Vaccine; 2006 Mar; 24(12):2213-21. PubMed ID: 16325310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication.
    Marconescu PS; Smallshaw JE; Pop LM; Ruback SL; Vitetta ES
    Vaccine; 2010 Jul; 28(32):5315-22. PubMed ID: 20562013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Mantis NJ
    J Biol Chem; 2017 Jan; 292(3):872-883. PubMed ID: 27903650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.
    Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G
    Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durable Immunity to Ricin Toxin Elicited by Intranasally Administered Monoclonal Antibody-Based Immune Complexes.
    Tolman LE; Yates JL; Rong Y; Reynolds-Peterson C; Ehrbar D; Torres-Velez FJ; Mantis NJ
    Immunohorizons; 2022 Jun; 6(6):324-333. PubMed ID: 35697476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.
    Smallshaw JE; Richardson JA; Vitetta ES
    Vaccine; 2007 Oct; 25(42):7459-69. PubMed ID: 17875350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-galactosylceramide (αGalCer) enhances vaccine-induced protection in a model of ricin intoxication.
    Yates JL; Leadbetter E; Mantis NJ
    Hum Vaccin Immunother; 2018; 14(8):2053-2057. PubMed ID: 29617191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies.
    Legler PM; Compton JR; Hale ML; Anderson GP; Olson MA; Millard CB; Goldman ER
    MAbs; 2017 Jan; 9(1):43-57. PubMed ID: 27660893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies.
    Vance DJ; Poon AY; Mantis NJ
    PLoS One; 2020; 15(11):e0236538. PubMed ID: 33166282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
    Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
    Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structures of ricin toxin's enzymatic subunit (RTA) in complex with neutralizing and non-neutralizing single-chain antibodies.
    Rudolph MJ; Vance DJ; Cheung J; Franklin MC; Burshteyn F; Cassidy MS; Gary EN; Herrera C; Shoemaker CB; Mantis NJ
    J Mol Biol; 2014 Aug; 426(17):3057-68. PubMed ID: 24907552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Shoemaker CB; Mantis NJ
    Proteins; 2016 Aug; 84(8):1162-72. PubMed ID: 27159829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin.
    Smallshaw JE; Richardson JA; Pincus S; Schindler J; Vitetta ES
    Vaccine; 2005 Sep; 23(39):4775-84. PubMed ID: 15961194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.